The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 718 participants.
Also called NCT03862859
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 718 participants
- Sponsor
- Registry
-
NCT03862859 -
2018-000484-86
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT03862859. Randomized; no masking; primary purpose prevention. Start 2019-10-09 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
- Acronym
- DANWARD
- Condition
- Atrial Fibrillation and Flutter
- Condition
- Stroke
- Condition
- Major Bleed
- Condition
- End-stage Renal Disease
- Intervention (Drug)
- Warfarin
- Lead sponsor
- Nicholas Carlson
- Collaborator
- Danish Heart Foundation
Record details
- Record id
cardio:ct-nct03862859- Content hash
28f176a764ff5587c75bfea82e7457ab55d2f9cfaf5aaf83797340397fe39ed6